Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | DRD4 | P21917 | 11/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 2/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2446015 | 0.85 | KMT2A (0.45) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL2448725 | 0.82 | KMT2A (0.55) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL2445278 | 0.82 | ALDH1A1 (0.35) | ALDH1A1MAPTPOLBL3MBTL1DRD4 | |
| SCHEMBL2322324 | 0.79 | ALDH1A1 (0.49) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL2448128 | 0.66 | ALDH1A1 (0.49) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL2320715 | 0.65 | ALDH1A1 (0.52) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL3354230 | 0.65 | ALDH1A1 (0.52) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL3347378 | 0.65 | ALDH1A1 (0.52) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL2317915 | 0.63 | ALDH1A1 (0.52) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 | |
| SCHEMBL12301198 | 0.62 | ALDH1A1 (0.44) | ALDH1A1MAPTPOLBL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110230471-A1 | BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230471-A1 | BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN | ENPP2, TPX2, TPD52L2 | ALDH1A1 4584/4885MAPT 2887/4885POLB 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.